Single-cell sequencing leads to a new era of cancer research
BGI, the world's largest genomics organization, developed single-cell genome sequencing technology and published two research papers for cancer single-cell sequencing in the research journal Cell. In the papers, which were p ...
Genetics
Mar 02, 2012 |
5 / 5 (4) |
0
Replicating risk genes in bipolar disorder
One of the biggest challenges in psychiatric genetics has been to replicate findings across large studies.
Psychology & Psychiatry
Oct 15, 2012 |
5 / 5 (3) |
0
FDA clears Pfizer drug for advanced kidney cancer
(AP) -- The Food and Drug Administration has approved a new Pfizer drug for patients with advanced kidney cancer that has spread to other parts of the body despite treatment with at least one previous drug.
Medications
Jan 27, 2012 |
5 / 5 (2) |
0
Identification of 'fingerprint' of rare tumor leads to development of cheap and reliable new test
Researchers at the University of Oxford have developed a cheap and reliable diagnostic test for a rare form of cancer. The test involves screening tumour samples for a particular molecular fingerprint unique ...
Cancer
May 19, 2011 |
5 / 5 (1) |
0
New findings provide more complete picture of kidney cancer
Two recent studies by Van Andel Research Institute scientists are providing a foundation for a more complete understanding of distinct kidney cancer subtypes, which could pave the way for better treatments.
Cancer
Dec 29, 2011 |
5 / 5 (1) |
0
Early clinical data show galeterone safe, effective against prostate cancer
Patients with castration-resistant prostate cancer had limited side effects and in many cases a drop in prostate-specific antigen expression with galeterone (TOK-001), a small-molecule oral drug, according to phase I data ...
Cancer
Apr 01, 2012 |
5 / 5 (1) |
0
Identifying patients who benefit most from immune suppressant
A new analysis may help doctors identify breast cancer patients who will benefit from treatment with the immune suppressant drug everolimus, say French researchers at the 4th IMPAKT Breast Cancer Conference in Brussels, Belgium.
Cancer
May 03, 2012 |
5 / 5 (1) |
0
Researchers find success with new immune approach to fighting some cancers
A national research collaboration of senior researchers, including a researcher from Moffitt Cancer Center, has found that 20 to 25 percent of "heavily pre-treated" patients with a variety of cancers who enrolled in a clinical ...
Cancer
Jun 13, 2012 |
5 / 5 (1) |
0
|
Two-drug combination may slow deadly thyroid cancer
A combination of the drugs pazopanib and paclitaxel shows promise in slowing anaplastic thyroid cancer (ATC), according to a Mayo Clinic-led study published in the journal Science Translational Medicine. The two drugs togeth ...
Cancer
Jan 08, 2013 |
5 / 5 (1) |
0
|
Some prostate cancer patients more likely to die after weekend ER visits
Patients with prostate cancer that has metastasized, or spread, to other parts of the body face a significantly higher risk of dying when visiting a hospital emergency department on the weekend instead of on a weekday, according ...
Cancer
May 05, 2013 |
5 / 5 (1) |
0
Cholesterol drugs might boost kidney cancer survival
(HealthDay)—Cholesterol-lowering statin drugs that are taken by millions of Americans might also improve survival from a type of kidney cancer called renal cell carcinoma, a new study suggests.
Cancer
May 07, 2013 |
5 / 5 (1) |
0
New compound holds high promise in battling kidney cancer
Chemists at the University of California, Riverside have developed a compound that holds much promise in the laboratory in fighting renal (kidney) cancer.
Cancer
Feb 19, 2013 |
1 / 5 (1) |
0
